A 4 ALA 0 -5.064 -4.482
A 5 ILE 0 -5.319 -4.708
A 6 ASN 0 -5.295 -4.686
A 7 ALA 7 -7.790 -7.699
A 8 PRO 2 -8.912 -8.117
A 9 VAL 16 -11.157 -11.714
A 10 THR 13 -12.826 -12.846
A 11 CYS 10 -12.568 -12.272
A 12 CYS 23 -12.245 -13.482
A 13 TYR 2 -9.695 -8.810
A 14 ASN 6 -9.176 -8.810
A 15 PHE 19 -8.260 -9.495
A 16 THR 19 -7.583 -8.896
A 17 ASN 1 -4.867 -4.422
A 18 ARG 3 -4.237 -4.095
A 19 LYS 11 -2.918 -3.847
A 20 ILE 32 -4.426 -7.597
A 21 SER 4 -2.887 -3.015 <=B
A 22 VAL 14 -2.987 -4.254
A 23 GLN 0 -2.383 -2.109 <=B
A 24 ARG 12 -5.003 -5.808
A 25 LEU 27 -6.204 -8.595
A 26 ALA 8 -6.704 -6.853
A 27 SER 6 -7.367 -7.210
A 28 TYR 32 -8.011 -10.770
A 29 ARG 18 -8.932 -9.975
A 30 ARG 7 -8.411 -8.249
A 31 ILE 26 -10.253 -12.064
A 32 THR 1 -8.496 -7.634
A 33 SER 13 -8.842 -9.320
A 34 SER 1 -8.420 -7.567
A 35 LYS 10 -9.130 -9.230
A 36 CYS 21 -9.692 -10.992
A 37 PRO 10 -7.649 -7.920
A 38 LYS 8 -6.999 -7.114
A 39 GLU 7 -8.319 -8.168
A 40 ALA 22 -9.342 -10.798
A 41 VAL 27 -9.195 -11.243
A 42 ILE 16 -10.642 -11.258
A 43 PHE 31 -9.337 -11.828
A 44 LYS 11 -9.002 -9.232
A 45 THR 11 -7.675 -8.058
A 46 ILE 5 -6.724 -6.525
A 47 VAL 3 -7.772 -7.223
A 48 ALA 0 -9.075 -8.031
A 49 LYS 12 -9.213 -9.533
A 50 GLU 13 -10.225 -10.544
A 51 ILE 24 -10.171 -11.761
A 52 CYS 13 -10.736 -10.997
A 53 ALA 28 -8.197 -10.474
A 54 ASP 10 -6.027 -6.484
A 55 PRO 13 -4.605 -5.570
A 56 LYS 4 -2.172 -2.382 <=B
A 57 GLN 17 -1.657 -3.421 <=B
A 58 LYS 0 0.549 0.485 <=B
A 59 TRP 15 -1.269 -2.848 <=B
A 60 VAL 20 -4.482 -6.266
A 61 GLN 4 -2.317 -2.511 <=B
A 62 ASP 9 -0.768 -1.715 <=B
A 63 SER 31 -2.867 -6.102
A 64 MET 16 -4.022 -5.399
A 65 ASP 7 -1.096 -1.775 <=B
A 66 HIS 18 -1.032 -2.983 <=B
A 67 LEU 22 -3.420 -5.557
A 68 ASP 11 -2.508 -3.484 <=B
A 69 LYS 7 0.255 -0.579 <=B
A 70 GLN 15 -0.761 -2.398 <=B
A 71 THR 3 -0.382 -0.683 <=B

Identified 14 B-Cell epitope residues out of 68 total residues